Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-22
SponsorInternational Agency for Research on Cancer

About this trial

This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.

Eligibility criteria

Qualifiers

Women aged 18 to 22 years, resident of Sikkim and married.

Pregnancy will not be considered as

Disqualifiers

Sample collection should be avoided during active menstruation.

Women who do not provide written consent

Women who are not able to cooperate in collection of cervical cell sample or respond to questions due to any acute or severe mental and physical illnesses.

Women who had undergone hysterectomy.

Trial design

Treatments tested in this trial

  • The study being observational in nature, there is no intervention. The investigators will only collect cervical samples from married women within a specified age range at different intervals.

Treatment groups

No treatment groups listed

Sponsors and collaborators

International Agency for Research on Cancer

Lead sponsor

Department of Health and Family welfare, Government of Sikkim

Collaborator

Sikkim Manipal Institute

Collaborator

Rajiv Gandhi Centre for Biotechnology

Collaborator